Contrast-induced nephropathy: Pharmacology, pathophysiology and prevention

Insights into Imaging

Volumn 4, Issue 6, 2013, Pages 811-820

  Geenen, Remy W F ^a   Kingma, Hylke Jan ^b   van der Molen, Aart J ^c  

^a Medical Centre Alkmaar   (Netherlands)

^b Stichting Apotheek der Haarlemse Ziekenhuizen   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical pharmacology; Contrast media; Guidelines as topic; Kidney diseases; Pharmacokinetics

Indexed keywords

EID: 84889579081     PISSN: None     EISSN: 18694101     Source Type: Journal    
DOI: 10.1007/s13244-013-0291-3     Document Type: Review

References (51)

1. Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L et al (2012) A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: definitions, conservative managment and contrast-induced nephropathy. Nephrol Dial Transplant 27: 4263-4272.
2. Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380: 756-766.
3. Stacul F, van der Molen A, Reimer P, Webb JAW, Thomsen HS, Morcos SK et al (2011) Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol 21: 2527-2541.
4. Thomsen HS, Morcos SK, Barrett BJ (2008) Contrast-induced nephropathy: The wheel has turned 360 degrees. Acta Radiol 49: 646-657.
5. Nash K, Hafeez A, Hou S (2002) Hospital-acquired renal insufficiency. Am J Kidney Dis 39: 930-936.
6. Karlsberg RP, Dohad SY, Sheng R (2010) Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media. J Nephrol 23: 658-666.
7. Kooiman J, Pasha SM, Zondag W, Sijpkens YWJ, van der Molen AJ, Huisman MV et al (2012) Meta-analysis: Serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 81: 2554-2561.
8. Balemans CEA, Reichert LJM, Schelven BIH, van den Brand JAJG, Wetzels JFM (2012) Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology 263: 706-713.
9. Kooiman J, Le Haen PA, Gezgin G, De Vries JPP, Boersma D, Brulez HF et al (2013) Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J 165: 793-799.
10. Rao QA, Newhouse JH (2006) Risk of nephropathy after intravenous administration of contrast material: A critical literature analysis. Radiology 239: 392-397.
11. Newhouse JH, Kho D, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: Implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191: 376-382.
12. McDonald JS, McDonald RJ, Comin J, Wiliamson E, Katzberg RW, Hassan Murad M et al (2013) Frequency of acute kidney injury following intravenous contrast medium administration: A systematic review and meta-analysis. Radiology 276: 119-128.
13. McDonald RJ, McDonald JS, Bida JP, Carter RE, Fleming CJ, Misra S et al (2013) Intravenous contrast material-induced nephropathy: causal of coincident phenomenon? Radiology 276: 106-118.
14. Davenport MS, Khalatbari Sm Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality contrast material: Risk stratification by using estimated glomerular filtration rate. Radiology 268: 719-728.
15. Wallingford VH (1953) The development of organic iodine compounds a x-ray contrast media. J Am Pharm Assoc (Baltim) 42: 721-728.
16. Speck U (1999) Contrast media: overview, use and pharmaceutical aspects, 4th edn. Springer, Berlin Heidelberg New York, pp 8-83.
17. Pollack HM (1998) History of iodinated contrast media. In: Thomson HS, Muller RN, Mattrey RF (eds) Trends in contrast media. Springer, Berlin Heidelberg New York, pp 3-19.
18. Fischer HM (1987) Historical aspects of contrast media. In: Felix R (ed) Contrast media from the past tot the future. Symposium Berlin 1987. Georg Thieme, Stuttgart New York, pp 3-18.
19. Almen T (1969) Contrast agent design. Some aspects on the synthesis of water soluble contrast agents of low osmolality. Theor Biol 24: 216-226.
20. Gonsette RE (1978) Animal experiments and clinical experiences in cerebral angiography with a new contrast agent (ioxaglic acid) with a low hyperosmolality. Ann Radiol (Paris) 21: 271-273.
21. Sovak M, Ranganathan R, Speck U (1982) Nonionic dimer: development and initial testing of an intrathecal contrast agent. Radiology 142: 115-118.
22. Scholz P, Weinmann HJ, Mützel W, Staks T (1989) Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd 128: 211-214.
23. Bolstad B, Borch KW, Grynne BH, Lundby B, Nossen JO, Kloster YF et al (1991) Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II. Invest Radiol 26(Suppl 1): S201-204.
24. Lenhard DC, Frisk AL, Lengsfeld P, Pietsch H, Jost G (2013) The effect of iodinated contrast agent properties on renal kinetics and oxygenation. Invest Radiol 48: 175-182.
25. SmPC texts of the ICMs via the College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board) in The Netherlands http://www. cbg-meb. nl/cbg/nl Last accessed 24/08/2013: Amidotrizoic acid (Urografin); Iobitridol (Xenetix); Iodixanol (Visipaque); Iohexol (Omnipaque); Iomeprol (Iomeron); Iopromide (Ultravist); Ioversol (Optiray); Ioxaglate (Hexabrix); Ioxitalaminic acid (Telebrix).
26. European Society of Urogenital Radiology contrast media Safety Committee guidelines. Accesible at: http://www. esur. org/guidelines/ Last accessed 24/08/2013.
27. Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332: 647-655.
28. Pallone TL, Turner MR, Edwards A, Jamison RL (2003) Countercurrent exchange in the renal medulla. Am J Physiol Regul Integr Comp Physiol 284: R1153-R1175.
29. Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3: 288-296.
30. Katzberg RW (2005) Contrast medium-induced nephrotoxicity; Which pathway? Radiology 235: 752-755.
31. Heyman SN, Reichman J, Brezis M (1999) Pathophysioloy of radiocontrast nephropathy. Invest Radiol 34: 685-691.
32. Persson PB, Hansell P, Liss P (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney International 68: 14-22.
33. Heyman SN, Rosenberger C, Rosen S (2005) Regional alterations in renal hemodynamcs and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20(Suppl 1): i6-i11.
34. Sendeski M, Patzak A, Pallone T, Cao C, Persson AE, Persson PB (2009) Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 251: 697-704.
35. Liu ZZ, Viegas VU, Perlewitx A, Lai EY, Persson PB, Patzak A et al (2012) Iodinated contrast media differentially affect afferent and efferent arteriolar tone and reactivity in mice: A possible explanation for reduced glomerular filtration rate. Radiology 265: 762-771.
36. Heyman SN, Rosen S, Khamaisi M, Idee JM, Rosenberger C (2010) Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 45: 188-195.
37. Haller C, Hizoh I (2004) The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 39: 149-154.
38. ACR manual on contrast media. Version 9 Accessible at: http://www. acr. org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/2013_Contrast_Media. pdf Last accessed 24/08/2013.
39. Fishbane S (2008) N-Acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 3: 281-287.
40. Ellis JH, Cohan RH (2009) Prevention of contrast-induced nephropathy: An overview. Radiol Clin N Am 47: 801-811.
41. Merten GJ, Burgess PW, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291: 2328-2334.
42. Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D et al (2007) The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO study. J Am Coll Cardiol 49: 1283-1288.
43. Pakfetrat M, Nikoo MH, Malekmakan L, Tabnadeh M, Roozbeh J, Nasab MH et al (2009) A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetezolamide for prevention of contrast-induced nephropathy: A randomized, double-blind trial. Int Urol Nephrol 41: 629-634.
44. Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA et al (2009) Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: A randomized controlled trial. Am J Kidney Dis 54: 610-618.
45. Briguori C, Airdoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaciio A et al (2007) Renal insufficiency following contrast media administration trial (REMEDIAL). A randomized comparison of 3 preventive strategies. Circulation 115: 1211-1217.
46. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y et al (2007) Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 100: 781-786.
47. Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C et al (2008) Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52: 599-604.
48. Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, Schneider H et al (2008) Renal insufficiency following radiocontrast exposure trial (REINFORCE): A randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coron Artery Dis 19: 413-419.
49. Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N et al (2007) Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimes for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 154: 539-544.
50. Brar SJ, Shen AYJ, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N et al (2008) Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography. A randomized trial. JAMA 300: 1038-1046.
51. Kooiman J, Sijpkens YW, Brulez HC, De Vries JPP, Hamming JF, van der Molen AJ et al (2013) Randomized study of short prehydration with sodium bicarbonate versus standard pre- and posthydration with sodium chloride to prevent contrast induced acute kidney injury: The Salina trial. Accessible at: http://circ. ahajournals. org/cgi/content/meeting_abstract/126/21_MeetingAbstracts/A12835?sid = 0f0efc3a-9dde-4b03-b193-6bf73e392d40 Last accessed 31/05/2013.